Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 887.172K |
Day Range | - - - |
52 Wk Range | 6.065 - 17.019 |
Market Cap | $530.228M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 37.37% |
Days to Cover | 12.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Phathom Pharmaceuticals (NASDAQ: PHAT) through any online brokerage.
Other companies in Phathom Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
The latest price target for Phathom Pharmaceuticals (NASDAQ: PHAT) was reported by Needham on Friday, April 19, 2024. The analyst firm set a price target for 26.00 expecting PHAT to rise to within 12 months (a possible 186.98% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $9.06 last updated April 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Phathom Pharmaceuticals.
Phathom Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Phathom Pharmaceuticals.
Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.